Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Equity Ratio (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Equity Ratio for 10 consecutive years, with 0.61 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 6.17% to 0.61 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.61, a 6.17% decrease, with the full-year FY2024 number at 0.62, down 13.62% from a year prior.
  • Equity Ratio was 0.61 for Q3 2025 at KORU Medical Systems, down from 0.65 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.92 in Q2 2021 to a low of 0.6 in Q1 2025.
  • A 5-year average of 0.75 and a median of 0.76 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: grew 1.88% in 2023, then dropped 16.55% in 2024.
  • KORU Medical Systems' Equity Ratio stood at 0.88 in 2021, then fell by 16.29% to 0.74 in 2022, then fell by 3.36% to 0.72 in 2023, then dropped by 13.62% to 0.62 in 2024, then dropped by 1.66% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Equity Ratio are 0.61 (Q3 2025), 0.65 (Q2 2025), and 0.6 (Q1 2025).